Emerging integrated therapies are reshaping the landscape of cancer treatment, with Hyperbaric Therapy now integrated alongside conventional methods like radiation and chemotherapy. This combined approach aims to optimize treatment dosages, induce tumor regression, and alleviate treatment side effects.
Research indicates that cancer cells thrive in oxygen-deprived environments, a common condition observed in cancer patients. By elevating oxygen levels, Hyperbaric Therapy has shown promise in impeding cancer growth and reducing its aggressiveness. Notably, studies from Oxford University demonstrate that oxygen injection into solid tumors enhances patient recovery chances and augments chemotherapy effectiveness.
Benefits of Hyperbaric Therapy in Cancer Care:
Cancer Prevention:
- Reduces inflammatory markers
- Normalizes intracellular oxygen levels
- Supports cellular detoxification
- Mitigates risk of inflammatory-related tumors
- Facilitates optimal DNA repair processes
Mental Health and Wellness:
- Enhances memory and cognitive function
- Stimulates neuroplasticity and executive function restoration
Enhancement of Conventional Cancer Therapies:
- Alleviates tumor hypoxia
- Improves radiation and chemotherapy outcomes
- Enhances brain tumor treatment efficacy
- Mitigates tumor drug resistance
Boosting Natural Killer Cell Activity:
- Increases oxy-radical production
- Amplifies apoptosis effect, leading to tumor regression
Reduction of Treatment Side Effects:
- Diminishes radiation and chemotherapy side effects
- Accelerates post-operative healing and infection prevention
- Alleviates symptoms of chemo-brain syndrome
Augmentation of IV Cancer Treatments:
- Enhances intravenous Vitamin C therapy
- Optimizes chemotherapy intake
Mitigation of Tumor Aggressiveness:
- Weakens hypoxic and metastatic tumors, targeting their progression
Cancer Studies
- Chemotherapy Drug Enhanced by HBOT: https://www.ihausa.org/pdf/adult-indications/cancer/chemotherapy-drug-enhanced-by-hbot.pdf
- HBOT Temozolomide for Glioblastomas: https://www.ihausa.org/pdf/adult-indications/cancer/hbot-temozolomide-for-glioblastomar.pdf
- HBOT for Brain Tumors: https://www.ihausa.org/pdf/adult-indications/cancer/hbot-for-brain-tumors.pdf
- HBOT for Chronic Radiation Injury: https://www.ihausa.org/pdf/adult-indications/cancer/hbot-for-chronic-radiation-injury.pdf
- HBOT Helps Reduce Lymphedema (breast cancer related): https://www.ihausa.org/pdf/adult-indications/cancer/hbot-helps-reduce-lymphedema-breast-cancer-related.pdf
- HBOT Significantly Reduces Tumor Volume in Ovarian Cancer: https://www.ihausa.org/pdf/adult-indications/cancer/hbot-significantly-reduces-tumor-volume-in-ovarian-cancer.pdf
- Hyperbaric Preconditioning Cisplatin-Induced Peripheral Neuropathy: https://www.ihausa.org/pdf/adult-indications/cancer/hyperbaric-preconditioning-cisplatin-induced-peripheral-neuropathy.pdf
- Ketogenic Diet HBOT Prolongs Survival in Metastatic Cancer: https://www.ihausa.org/pdf/adult-indications/cancer/ketogenic-diet-hbot-prolongs-survival-in-metastatic-cancer.pdf
- Stage 4 Breast Cancer Responds to Combination Therapy Including HBOT: https://www.ihausa.org/pdf/adult-indications/cancer/stage-4-breast-cancer-responds-to-combination-therapy-including-hbot.pdf
- Survival Outcomes of Metabolically Supported Treatment with HBOT in Gastric Cancer: https://www.ihausa.org/pdf/adult-indications/cancer/survival-outcomes-of-metabolically-supported-treatement-with-hbot-in-gastric-cancer.pdf
